File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Effect of rapamycin on renal ischemia reperfusion injury

TitleEffect of rapamycin on renal ischemia reperfusion injury
Authors
Issue Date2006
PublisherFederation of Medical Societies of Hong Kong
Citation
Hong Kong Society of Nephrology Annual Scientific Meeting, Hong Kong, 10-11 September 2005. In The Hong Kong Medical Diary, 2006, v. 11 n. 5, p. 19 How to Cite?
AbstractBackground: The aim of this study was to determine the effect of rapamycin (Rapa), a relatively new immunosuppressive drug, on renal ischemia reperfusion injury (IRI) in the mouse. Methods: Renal IRI was induced in male Balb/c mice by clamping both renal pedicles for 45 minutes. The mice were treated with either vehicle or Rapa (2 mg/kg/day) by oral gavage, starting 2 days before the IRI and continued daily until sacrifice. The mice were sacrificed at 1, 3, and 7 days after the operation. The severity of the IRI was assessed by serum creatinine levels and renal histology. Proliferation of renal tubular cells was quantified by immunohistochemical staining for proliferating cell nuclear antigen (PCNA). Results: One day after the IRI, the serum creatinine levels of Rapa-treated mice were significantly higher than those of vehicle-treated mice. Kidney sections from Rapa-treated mice also showed more marked tubular damage on day 1. The number of PCNApositive cells in Rapa-treated mice was significantly lower than that in vehicle-treated mice on days 1 and 3 after IRI. By day 7 after IRI, there was no significant difference between Rapa- and vehicle-treated mice in terms of serum creatinine levels, renal histology and positive PCNA staining. Conclusion: We conclude that Rapa treatment aggravates renal IRI during the first 1 to 3 days after the insult. This effect might be partly mediated through inhibition of renal tubular cell regeneration.
Persistent Identifierhttp://hdl.handle.net/10722/101688
ISSN

 

DC FieldValueLanguage
dc.contributor.authorLui, SLen_HK
dc.contributor.authorChan, KWen_HK
dc.contributor.authorTsang, RCWen_HK
dc.contributor.authorYung, SSYen_HK
dc.contributor.authorLai, KNen_HK
dc.contributor.authorChan, DTMen_HK
dc.date.accessioned2010-09-25T19:59:47Z-
dc.date.available2010-09-25T19:59:47Z-
dc.date.issued2006en_HK
dc.identifier.citationHong Kong Society of Nephrology Annual Scientific Meeting, Hong Kong, 10-11 September 2005. In The Hong Kong Medical Diary, 2006, v. 11 n. 5, p. 19-
dc.identifier.issn1812-1691-
dc.identifier.urihttp://hdl.handle.net/10722/101688-
dc.description.abstractBackground: The aim of this study was to determine the effect of rapamycin (Rapa), a relatively new immunosuppressive drug, on renal ischemia reperfusion injury (IRI) in the mouse. Methods: Renal IRI was induced in male Balb/c mice by clamping both renal pedicles for 45 minutes. The mice were treated with either vehicle or Rapa (2 mg/kg/day) by oral gavage, starting 2 days before the IRI and continued daily until sacrifice. The mice were sacrificed at 1, 3, and 7 days after the operation. The severity of the IRI was assessed by serum creatinine levels and renal histology. Proliferation of renal tubular cells was quantified by immunohistochemical staining for proliferating cell nuclear antigen (PCNA). Results: One day after the IRI, the serum creatinine levels of Rapa-treated mice were significantly higher than those of vehicle-treated mice. Kidney sections from Rapa-treated mice also showed more marked tubular damage on day 1. The number of PCNApositive cells in Rapa-treated mice was significantly lower than that in vehicle-treated mice on days 1 and 3 after IRI. By day 7 after IRI, there was no significant difference between Rapa- and vehicle-treated mice in terms of serum creatinine levels, renal histology and positive PCNA staining. Conclusion: We conclude that Rapa treatment aggravates renal IRI during the first 1 to 3 days after the insult. This effect might be partly mediated through inhibition of renal tubular cell regeneration.-
dc.languageengen_HK
dc.publisherFederation of Medical Societies of Hong Kong-
dc.relation.ispartofThe Hong Kong Medical Diaryen_HK
dc.titleEffect of rapamycin on renal ischemia reperfusion injuryen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailLui, SL: sllui@HKUCC.hku.hken_HK
dc.identifier.emailChan, KW: hrmtckw@hku.hken_HK
dc.identifier.emailYung, SSY: ssyyung@hku.hken_HK
dc.identifier.emailLai, KN: knlai@hku.hken_HK
dc.identifier.emailChan, DTM: dtmchan@hku.hken_HK
dc.identifier.authorityYung, SSY=rp00455en_HK
dc.identifier.authorityLai, KN=rp00324en_HK
dc.identifier.authorityChan, DTM=rp00394en_HK
dc.identifier.hkuros104866en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats